Prostate cancer is one of the least immunogenic malignancies and poorly responds to immunotherapies. Characterized by an immunosuppressive tumor microenvironment and a scarcity of cytotoxic T-cell infiltrates, prostate cancer has been closely linked to extracellular vesicles (EVs), including exosomes and microvesicles,...
Abstract Prostate cancer (PCa) remains a major clinical challenge because of limitations in early detection, tumor heterogeneity, therapeutic resistance, and metastatic progression. Nanomaterials provide versatile platforms for PCa theranostics by integrating molecular imaging, biomarker detection, targeted delivery, m...
Jia Wang, Zhongsong Zhang, Haihao Li et al.· International Journal of Nan...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.